Margarida Rodrigues

Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme

Eva‐Maria Gamper, Lisa M. Wintner, Margarida Rodrigues et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 96 citations · Full text

Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle

Bernhard Nilica, Dietmar Waitz, Vlado Stevanovic et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 90 citations · Full text

Quality of Life in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy: Information from a Monitoring Program in Clinical Routine

Caroline Martini, Sabine Buxbaum, Margarida Rodrigues et al. · Journal of Nuclear Medicine · 2018 · 25 citations · Full text

Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET

Margarida Rodrigues, Tatjana Traub‐Weidinger, M. Leimer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2005 · 23 citations

Medicine, 18F-fdg Pet, Thyroid Disease +9

99mTc-Depreotide Scintigraphy Versus18F-FDG-PET in the Diagnosis of Radioiodine-Negative Thyroid Cancer

Margarida Rodrigues, Shuren Li, Michael Gabriel et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 23 citations · Full text